SRF and CBP jointly regulate integrin β6 overexpression in head and neck squamous cell carcinomas.

Cell Signal

Department of Basic Medical Science & Department of Stomatology, School of Medicine, Xiamen University, Xiamen, Fujian, China. Electronic address:

Published: January 2025

Overexpression of integrin β6 (ITGB6) is crucially linked to the invasion and metastasis of head and neck squamous cell carcinoma (HNSCC). The molecular mechanisms driving ITGB6 upregulation in HNSCC are not well understood. Our study comprehensively analyzed the transcriptional regulation and epigenetic modification mechanisms affecting ITGB6 transcription. We retrospectively evaluated ITGB6 expression using immunohistochemistry on a tissue microarray. Elevated ITGB6 expression in HNSCC specimens correlates with poor clinical prognosis. Using a luciferase reporter assay, site-directed mutagenesis, RNA interference, chromatin immunoprecipitation assay, and a 4-nitroquinoline 1-oxide (4NQO)-induced murine HNSCC model, we have demonstrated that the transcription factor Serum Response Factor (SRF) upregulates ITGB6 transcription. Our results further demonstrated that the histone acetyltransferase (HAT) CBP mediates the hyperacetylation of histones H3 and H4, facilitating their recruitment to the ITGB6 promoter. This recruitment strengthens SRF binding to the ITGB6 promoter. These findings suggest that SRF and CBP-mediated histone hyperacetylation are crucial for ITGB6 overexpression in HNSCC. Epigenetic mechanisms play a critical role in the active transcriptional expression of ITGB6 in HNSCC cells.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cellsig.2025.111621DOI Listing

Publication Analysis

Top Keywords

itgb6
10
integrin β6
8
head neck
8
neck squamous
8
squamous cell
8
itgb6 transcription
8
itgb6 expression
8
itgb6 promoter
8
hnscc
6
srf
4

Similar Publications

SRF and CBP jointly regulate integrin β6 overexpression in head and neck squamous cell carcinomas.

Cell Signal

January 2025

Department of Basic Medical Science & Department of Stomatology, School of Medicine, Xiamen University, Xiamen, Fujian, China. Electronic address:

Overexpression of integrin β6 (ITGB6) is crucially linked to the invasion and metastasis of head and neck squamous cell carcinoma (HNSCC). The molecular mechanisms driving ITGB6 upregulation in HNSCC are not well understood. Our study comprehensively analyzed the transcriptional regulation and epigenetic modification mechanisms affecting ITGB6 transcription.

View Article and Find Full Text PDF

Exposure to diesel exhaust is associated with increased risk of cardiovascular and lung disease. Substituting petroleum diesel with renewable diesel can alter emission properties but the potential health effects remain unclear. This study aimed to explore toxicity and underlying mechanisms of diesel exhaust from renewable fuels.

View Article and Find Full Text PDF

Integrin β6/Annexin A2 axis triggers autophagy to orchestrate hepatocellular carcinoma radioresistance.

Cell Death Differ

November 2024

Center of Hepato-Pancreato-Biliary Surgery, First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.

Radiotherapy (RT) is one of the main therapies for hepatocellular carcinoma (HCC), but its effectiveness has been constrained due to the resistance effect of radiation. Thus, the factors involved in radioresistance are evaluated and the underlying molecular mechanisms are also done. In this present study, we identified Integrin β6 (ITGB6) as a potential radioresistant gene through an integrative analysis of transcriptomic profiles, proteome datasets and survival using HCC cases treated with IR.

View Article and Find Full Text PDF
Article Synopsis
  • Diabetic kidney disease (DKD) often leads to acute kidney injury (AKI), making it essential to develop strategies to prevent and treat these conditions.
  • Researchers analyzed datasets from healthy individuals and patients with AKI and DKD to identify common differentially expressed genes (DEGs) and construct gene interaction networks for further analysis.
  • Four key DEGs were highlighted, particularly Integrin Subunit Beta 6, which may serve as a potential biomarker for early AKI diagnosis and a target for therapeutic interventions in DKD patients.
View Article and Find Full Text PDF

Emerging Targets in Non-Small Cell Lung Cancer.

Int J Mol Sci

September 2024

Samuel-Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.

Lung cancer is responsible for a high burden of disease globally. Over the last two decades, the discovery of targetable oncogenic genomic alterations has revolutionized the treatment landscape for early-stage and advanced non-small cell lung cancer (NSCLC). New molecular drivers continue to emerge as promising therapeutic targets, including KRAS non-G12C, RAF/MEK, HER3, Nectin-4, folate receptor alpha, ITGB6, and PRMT5.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!